MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced financial and operational results for the third quarter ended September 30, ...

Oral GLP-1 RA peptide program clinical trial initiated Metsera has initiated a clinical trial ... and candidates targeting other complementary NuSH pathways, including glucagon and PYY, as well as ...

DA-1241 is a novel G-protein-coupled receptor 119 (GPR119) agonist that promotes the release of key gut peptides GLP-1, GIP, and PYY. In pre-clinical studies, DA-1241 demonstrated a positive effect on ...

Dietary fibre encourages our intestinal micro-organisms to manufacture short-chain fatty acids (SCFAs). These stimulate the production of leptin and also the short-term appetite suppressants PYY and ...

Who needs Ozempic to stop feeling hungry? Yes, the active ingredient semaglutide in the weight loss wonder drug helps to keep ...

The theme is 40 micro-cap companies with a catalyst and/or strong performance in the current market.

Eating an entire rotisserie chicken all by your lonesome may sound like a fun and delicious challenge. But it can affect your ...

Medically reviewed by Ashley Baumohl, RD Chicken and eggs are popular animal-derived protein sources that are packed with ...

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the completion of the ...

What Are GLP-1 Medications and How Do They Work? GLP-1 (glucagon-like peptide-1) medications work by mimicking a hormone that regulates blood sugar and appetite. They slow down digestion ...

The new menu includes five smoothies “created to assist the millions of Americans currently taking prescription GLP-1 medications" Sabrina Weiss is the Editorial Assistant of PEOPLE's food ...

PHILADELPHIA — The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with a significant decrease in the risk for early-onset colorectal cancer (EO-CRC) in patients with ...